By Ashleigh Fields
On the South Side of Chicago, Black men have collectively prioritized and mobilized on issues paramount to their demographic. Prostate cancer, lung...
By: Adrelia Allen, Senior Director, Clinical Trial Patient Diversity, Merck Research
Clinical trials are a critical part of the research process for new medicines and...
Better access to healthcare equals better health outcomes. Biogen strives to increase access and address the barriers that patient populations face. Oftentimes, health outcomes...
By: Luther T. Clark, MD
Deputy Chief Patient Officer, Merck
The COVID-19 pandemic has shone a light on longstanding health care disparities and amplified the importance...
By: Luther T. Clark, MD, Deputy Chief Patient Officer, Merck
Barriers to participation of racially and ethnically underrepresented patients in clinical trials include: (1) mistrust,...
The FDA recently showcased the demographic characteristics of study volunteers in clinical trials for drugs that gained approval in 2019. Of the 46,391 participants,...
